Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Patrys Limited
  6. News
  7. Summary
    PAB   AU000000PAB9

PATRYS LIMITED

(PAB)
Delayed Australian Stock Exchange  -  02:10 2022-09-23 am EDT
0.0230 AUD   -4.17%
08/30Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director
CI
08/30Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/29Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PATRYS LIMITED
08/30Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director
CI
08/30Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/29Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification..
CI
08/26Research Institute Secures Grant Funding to Study Use of Patrys' Drugs as Breast Cancer..
MT
08/10Patrys Validates Efficacy of Brain Cancer Drug in Preclinical Animal Study
MT
08/09Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1
CI
08/07Patrys Chair to Retire End-August
MT
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
07/04Patrys Produces Antibody Drug at Commercial Scale
MT
07/03Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run
CI
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
04/14PATRYS : Application for quotation of securities - PAB
PU
03/23NEW RESEARCH : Scientists determine structure of a DNA damage ‘First Responder' prot..
PU
More most relevant news
All news about PATRYS LIMITED
08/30Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director
CI
08/30Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/29Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification..
CI
08/26Research Institute Secures Grant Funding to Study Use of Patrys' Drugs as Breast Cancer..
MT
08/10Patrys Validates Efficacy of Brain Cancer Drug in Preclinical Animal Study
MT
08/09Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1
CI
08/07Patrys Chair to Retire End-August
MT
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
07/04Patrys Produces Antibody Drug at Commercial Scale
MT
07/03Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run
CI
More news
News in other languages on PATRYS LIMITED
08/30Patrys Limited annonce la nomination de M. Stefan Ross en tant que directeur non exécut..
08/30Patrys Limited annonce ses résultats pour l'exercice complet terminé le 30 juin 2022
08/29Patrys Limited annonce une mise à jour sur le PAT-DX1 de l'essai d'ingénierie qui répon..
08/26L'institut de recherche obtient une subvention pour étudier l'utilisation des médicamen..
08/10Patrys valide l'efficacité d'un médicament contre le cancer du cerveau dans une étude p..
08/09Patrys Limited annonce de nouvelles données précliniques pour son actif principal, Pat-..
07/04Patrys produit un médicament anticorps à l'échelle commerciale
07/03Patrys Limited annonce l'achèvement réussi de l'essai d'ingénierie du Pat-Dx1
06/03Patrys obtient une subvention pour développer un médicament contre le cancer du cerveau
02/27Patrys Limited annonce une lignée cellulaire stable pour la production de PAT-DX3
More news
Press releases
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
04/14PATRYS : Application for quotation of securities - PAB
PU
03/23NEW RESEARCH : Scientists determine structure of a DNA damage ‘First Responder' prot..
PU
02/24PATRYS : Appendix 4D - Half Year Accounts - 31 December 2021
PU
More press releases
Upcoming event on PATRYS LIMITED